U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418918) titled 'Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)' on Feb. 04.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled phase IIb clinical study, to evaluate the efficacy and safety of the dual - live Lactobacilli-containing vaginal capsule for the treatment of bacterial vaginosis.
Study Start Date: Jan. 03, 2023
Study Type: INTERVENTIONAL
Condition:
Bacterial Vaginosis
Intervention:
DRUG: Vaginal Lactobacillus Dual Probiotic Capsules
Vaginal Lactobacillus Dual Probiotic Capsules, at the prescribed dose and course of treatment, for regulating vaginal microecology.
DRUG: Placebo
Placeb...